S81560 |
CGI-1746 |
源叶(MedMol) | 96% |
- 提示:详情请下载说明书。
- 产品描述: CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.
- 靶点: IC50: 1.9 nM (Btk);BTK; Autophagy
- 体内研究:
CGI1746 abrogates B cell-dependent arthritis. CGI1746 treatment (100 mg/kg, s.c, twice-daily dosing) results in significant inhibition (97%) of overall clinical arthritis scores. CGI1746 treatment substantially reduces TNFα, IL-1β and IL-6, as well as MCP1 and MIP-1α on both the mRNA and protein level in the passive anti-collagen II antibody-induced arthritis (CAIA) model. CGI1746 shows comparable efficacy to TNFα blockade and significantly reduces clinical scores, as well as joint inflammation, in mice or rats with established arthritis
- 参考文献:
1. Di Paolo, Julie A. et al. Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis. Nature Chemical Biology (2011), 7(1), 41-50 2. Kokabee L, et al. Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer. Cancer Biol Ther. 2015;16(11):1604-15
- 溶解性: DMSO : ≥ 50 mg/mL (86.25 mM)
- 保存条件: -20℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 1.725 ml 8.625 ml 17.25 ml 5 mM 0.345 ml 1.725 ml 3.45 ml 10 mM 0.173 ml 0.863 ml 1.725 ml 50 mM 0.035 ml 0.173 ml 0.345 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)